MASS 908 Devices Inc.
XNAS
10.40
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
MASS
$10.40
—
What changed
Recent filings, trades and movesKey stats
$10.40
- 52-Week Range
- $5.03 – $13.35
- YTD
- +104.42%
- IV Rank (30D)
- 29.12
- Straddle Price
- $2.20
- P/C Vol Ratio
- 0.35
- Market Cap
- $0.5B
- Open
- $10.42
- Day Range
- $10.28 – $10.69
- Volume
- 12,859
- Prev Close
- $9.98
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.84% |
| Beta vs SPY | 1.47 |
| Cost of Equity (CAPM) | 12.92% (VRP-adj) |
| WACC | 13.04% |
| Volatility Risk Premium | +45.8pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +14.8% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | -27.3% |
| Book / Price | 29.2% |
| Gross Margin (TTM) | 52.2% |
| FCF Margin (TTM) | 1.0% |
| Debt / Equity | 0.00 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $11.21 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $11.49 |
| Bollinger Width / SMA20 | 25.3% (drives anchor stability) |
| Net Debt | $-0.1B |
| Market Cap | $0B |
Peers used for multiples: ABSI, CRSP, GH, LLY, NTRA, TEM, TWST, TXG
60-Day Conviction
97%
20-Day Fair Value
≈ by Dec 9, 2026
$9.99
α +0.1%
rank 93%
conviction
5%
40-Day Fair Value
≈ by Jan 7, 2027
$10.52
α +5.4%
rank 95%
conviction
97%
60-Day Fair Value
≈ by Feb 5, 2027
$10.69
α +7.1%
rank 95%
conviction
97%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $1.97 | 33% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | |
| Peer EV/EBITDA | n/a | 0% | |
| Peer P/B | $60.38 | 13% | median 18.0× · 7 peers |
| Peer P/S | $27.89 | 13% | median 15.7× · 8 peers |
| Market Anchor (SMA50) | $11.21 | 41% | stability 62% (BB-width) |
| Options Expected (B-L 30d) | $11.88 | 0% | 5 strikes · skew +0.36 |
As of 2026-11-10 · updated
Related
About
- Industry (SIC)
- LABORATORY ANALYTICAL INSTRUMENTS (3826) · industry map
- Exchange
- XNAS
- Market Cap
- $0.5B
- Employees
- 172
- List Date
- 2020-12-18
- CIK
- 0001555279
- Last Earnings
- Nov 10 before open · −13.3% vs ±21.5% expected
- Next Earnings
- ~Mar 2, 2027 (estimated)
- Headquarters
- Burlington, MA
- Homepage
- https://www.908devices.com
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company re…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 0.73% | -39.80% | 26.98% | -28.63% | 14.16% | 23.97% | -0.43% |
| Feb | -3.01% | 2.02% | -4.56% | 1.94% | -2.18% | 11.47% | 0.95% |
| Mar | -15.61% | 14.11% | -2.60% | 2.72% | 126.26% | -7.41% | 19.58% |
| Apr | 1.69% | -13.88% | -20.66% | -17.39% | 33.42% | 9.98% | -1.14% |
| May | -19.49% | -24.02% | 40.03% | 10.92% | 5.97% | 23.49% | 6.15% |
| Jun | -12.82% | 52.86% | -21.60% | -16.94% | 19.83% | 0.81% | 3.69% |
| Jul | -15.79% | 4.94% | -0.14% | 19.29% | 1.08% | -9.80% | -0.07% |
| Aug | 14.98% | -10.84% | 8.61% | -22.24% | -2.65% | 26.72% | 2.43% |
| Sep | -9.92% | -10.11% | -6.33% | -6.72% | 47.47% | 15.87% | 5.04% |
| Oct | -5.95% | -3.44% | -6.91% | -7.79% | -11.23% | -10.07% | -7.57% |
| Nov | -32.57% | -31.80% | 29.01% | -20.81% | -19.92% | -2.20%* | -13.05% |
| Dec | 7.79% | -27.43% | 45.71% | -23.34% | -14.50% | -- | -2.35% |
| Total | -64.91% | -71.82% | 82.78% | -72.45% | 277.55% | 104.06% | 42.53% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $11.33
SMA 50: $11.19
SMA 200: $8.53
Current: $10.67
EMA 12: $10.96
EMA 26: $11.20
MACD: -0.2398 | Signal: -0.1502
BEARISH
ADX (14): 21.46
WEAK TREND
+DI: 19.14
−DI: 27.80
Momentum Oscillators
RSI (14): 46.49
NEUTRAL
Stoch %K: 28.90
Stoch %D: 28.70
Williams %R: -72.76
Volume & Volatility
BB Upper: $12.91
BB Lower: $9.75
NEUTRAL
OBV: 146,394,089
Vol SMA 20: 369,516
Vol ROC: -96.02%
ATR: $0.84
True Range: $0.71
HV 20: 104.2%
HV 30: 88.0%
HV 60: 73.2%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-11-12T00:00:00 – 2026-11-10T00:00:00
AI Analysis
Written before MASS’s Nov 10 earnings report, so it doesn’t reflect the results.
LLM Stock Analysis Report - MASS
Executive Summary
Overall Assessment: BULLISH (Confidence Level: 8/10)
Key Drivers:
- Strong technical signals, including a bullish MACD crossover
- Positive news sentiment with recent revenue growth announcements
- High volatility and beta indicate potential for significant price movements
Primary Risks:
- Overbought RSI reading (>70) suggests potential for a pullback
- High implied volatility (142%) may lead to increased options trading activity
Investment Thesis: MASS presents an attractive buying opportunity due to its strong technical signals, positive news sentiment, and high beta. However, caution should be exercised due to the overbought RSI reading.
Recent News Sentiment Impact: The recent news headlines have been largely neutral or positive, contributing to the overall bullish assessment.
Technical Analysis
Trend Direction:
- Short-term: Bullish (uptrend)
- Medium-term: Bullish (uptrend)
- Long-term: Bullish (uptrend)
Support/Resistance Levels:
- Upper Bollinger Band: $11.68
- Middle Bollinger Band: $9.72
- Lower Bollinger Band: $7.75
Momentum Signals: RSI: 71.60 (overbought) MACD: Bullish crossover above signal line Bollinger Bands: Price touching upper band, indicating overbought conditions
Volume Analysis: Volume SMA 20: 537754.58 On-Balance Volume (OBV): 142723152.72 Volume Rate of Change: -3.14% (indicating a potential reversal)
News & Sentiment Analysis
Recent Headlines Summary:
- Revenue growth announcements have been the primary focus, with no significant negative news.
Sentiment Assessment: The sentiment is generally positive, with 4 out of 6 recent headlines having a neutral or positive tone.
Catalyst Identification: No specific catalysts are identified in the recent news, but the company's revenue growth may continue to drive prices higher.
Market Narrative: The news aligns with the technical signals, reinforcing the bullish trend.
Risk & Volatility Assessment
Risk Assessment:
- Beta: 1.42 (high risk)
- Implied volatility: 142% (high risk)
Volatility Regime:
- Current vs historical volatility levels: Higher than normal
- IV Rank: 20.6% (Low) - shows if volatility is historically high/low)
Options Market Signals: IV rank: 20.6% (Low) Current IV: 142.0% Expected Move: $2.17 (22 DTE), 7-DTE: $2.17 Volume Flow: 29 calls vs 8 puts Open Interest: 578 calls vs 17 puts
Downside Protection: Support levels and risk management considerations should be taken into account to mitigate potential losses.
Market Context & Positioning
Sector Performance: MASS is outperforming the sector and market, indicating strong relative strength.
Institutional Activity: Institutional interest is high, with a volume flow of 29 calls vs 8 puts.
Correlation Analysis: The stock has a low correlation (0.29) to the broader market, suggesting it may be less susceptible to market fluctuations.
Relative Valuation: MASS is positioned within its trading range, making it an attractive buying opportunity.
Key Levels & Action Items
Critical Price Levels:
- Lower Bollinger Band: $7.75
- Middle Bollinger Band: $9.72
Breakout/Breakdown Levels:
- Upper Bollinger Band: $11.68 (breakout level)
Time-Sensitive Catalysts: No specific catalysts are identified in the recent news, but the company's revenue growth may continue to drive prices higher.
Risk Management: Stop-loss levels and position sizing considerations should be taken into account to mitigate potential losses.
Conclusion MASS presents an attractive buying opportunity due to its strong technical signals, positive news sentiment, and high beta. However, caution should be exercised due to the overbought RSI reading and high implied volatility. A stop-loss level at the lower Bollinger Band ($7.75) may help mitigate potential losses.
Generated
News
All MASS news →
NIRLab scan volume climbed 74% as the installed base passed 4,400 devices.
Earnings History
18 of 20 under expected move
Avg Expected Move
27.61%
Avg Actual Move
6.29%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-08-04 | After-Close | 5.38% | 1.28% | 0.24x | Within |
| 2021-11-04 | After-Close | 9.31% | 3.29% | 0.35x | Within |
| 2022-01-10 | After-Close | 44.96% | 5.85% | 0.13x | Within |
| 2022-03-07 | After-Close | 12.36% | 15.06% | 1.22x | Exceeded |
| 2022-08-09 | After-Close | 9.60% | 4.00% | 0.42x | Within |
| 2022-11-14 | After-Close | 8.73% | 15.87% | 1.82x | Exceeded |
| 2023-05-09 | After-Close | 20.71% | 2.11% | 0.10x | Within |
| 2023-08-08 | After-Close | 8.50% | 3.53% | 0.42x | Within |
| 2023-11-07 | After-Close | 24.53% | 8.69% | 0.35x | Within |
| 2024-03-05 | After-Close | 42.82% | 2.73% | 0.06x | Within |
| 2024-04-30 | After-Close | 26.49% | 0.35% | 0.01x | Within |
| 2024-08-06 | After-Close | 21.60% | 4.97% | 0.23x | Within |
| 2024-11-12 | After-Close | 103.60% | 19.86% | 0.19x | Within |
| 2025-03-04 | After-Close | 44.46% | 13.14% | 0.30x | Within |
| 2025-05-13 | After-Close | 33.33% | 7.10% | 0.21x | Within |
| 2025-08-05 | After-Close | 21.29% | 3.08% | 0.14x | Within |
| 2025-11-10 | After-Close | 34.40% | 7.82% | 0.23x | Within |
| 2026-03-03 | After-Close | 30.46% | 6.65% | 0.22x | Within |
| 2026-05-06 | After-Close | 27.61% | 0.25% | 0.01x | Within |
| 2026-08-11 | After-Close | 21.98% | 0.10% | 0.00x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
MASS Options Activity & IV Rank
MASS IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 83.9%
7-DTE IV: 92.7%
Expected Move: $2.20
7-DTE Move: $1.15
Days to Exp: 37 (2026-12-18)
Options Flow · All expiries
Call Volume: 57
Put Volume: 20
P/C Volume: 0.351
BULLISH
Call OI: 468
Put OI: 766
P/C OI: 1.637
Total OI: 1,234
ATM Options Pricing
ATM Call: $1.32
ATM Put: $0.88
Call %: 12.7%
Put %: 8.4%
Chain Summary
Chain Volume: 77
Chain OI: 1,234
Last Updated: 11/11/2026
Spread Scanner
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Dealer Positioning
LOW γ vs HISTORY
Estimated net dealer gamma is at the 7th percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
7%
vs own history
GEX tilt
-0.40
OI-weighted, today
Vanna tilt
+0.94
δ-sensitivity to IV
Charm tilt
-0.80
δ-decay vs time
Vanna tilt +0.94: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.80: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 4 ATM contracts, 0k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
No data
30 DTE / 10d
—
—
pts
EXTREME
No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Loading the implied volatility surface…
Volatility Smile
Loading the implied volatility smile…
IV Rank (7 DTE)7.0LowNov 11
IV Rank (30 DTE)29.1MediumNov 11
Straddle Price (30 DTE)$2.20Nov 11
Beta Analysis
Risk Metrics
Beta: 1.8710
Alpha: 45.31%
Correlation: 0.3988
R-Squared: 15.9%
Stock Volatility: 64.1%
Market Volatility: 13.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own MASS
2 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $1.7M | #2066 of 3138 | -16.6% | 13F | |
| Citadel Hedge fund Ken Griffin | $546K | #4367 of 6285 | -56.6% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
MASS Institutional Ownership (13F)
Filings for 2026-06-30 · 41 already for 2026-09-30
? 13F Guide
Diluted shares outstanding: 36,719,014 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
3 filers$1.14M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $777.78K | 68.12% | 2026-06-30 |
| 2 | IMC-Chicago, LLC Custodian | $350.46K | 30.69% | 2026-09-30 |
| 3 | Simplex Trading, LLC Custodian | $13.57K | 1.19% | 2026-09-30 |
1 filers$124.63K notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | IMC-Chicago, LLC Custodian | $124.63K | 100.00% | 2026-09-30 |
MASS Insider Trading (Form 4)
Latest: 2026-11-06Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-06 | Christopher D. Brown | Director | Sell (S) | −30,000 | $10.95 | -$328.5K | EDGAR |
| 2026-10-09 | Christopher D. Brown | Director | Mixed Sell −30,000 · Exer +60,000 |
+30,000 | $5.13 | -$251.7K | EDGAR |
| 2026-10-08 | Joseph H. Griffith IV | Chief Financial Officer | Sell (S) | −5,000 | $13.03 | -$65.2K | EDGAR |
| 2026-10-01 | AWM Investment Company, Inc. | 10%+ Owner | Sell (S) | −18,000 | $11.52 | -$207.3K | EDGAR |
| 2026-09-25 | AWM Investment Company, Inc. | 10%+ Owner | Sell (S) | −25,000 | $11.36 | -$283.9K | EDGAR |
| 2026-09-17 | John Kenneweg | SVP, Sales & Product Marketing | Mixed Sell −27,656 · Exer +27,656 |
— | $5.54 | -$253.5K | EDGAR |
| 2026-09-04 | Christopher D. Brown | Director | Sell (S) | −30,000 | $10.58 | -$317.4K | EDGAR |
| 2026-08-27 | Joseph H. Griffith IV | Chief Financial Officer | Sell (S) | −11,459 | $10.95 | -$125.5K | EDGAR |
| 2026-08-24 | AWM Investment Company, Inc. | 10%+ Owner | Sell (S) | −50,000 | $10.60 | -$529.8K | EDGAR |
| 2026-08-17 | Kevin J. Knopp | President and CEO | Sell (S) | −27,622 | $10.27 | -$283.7K | EDGAR |
| 2026-08-12 | Christopher D. Brown | Director | Sell (S) | −17,800 | $9.12 | -$162.4K | EDGAR |
| 2026-08-12 | Kevin J. Knopp | President and CEO | Sell (S) | −149,013 | $9.90 | -$1.48M | EDGAR |
| 2026-08-07 | Christopher D. Brown | Director | Sell (S) | −20,000 | $8.49 | -$169.8K | EDGAR |
| 2026-08-06 | AWM Investment Company, Inc. | 10%+ Owner | Sell (S) | −50,000 | $8.36 | -$417.8K | EDGAR |
| 2026-08-03 | Brandi C Vann | Director | Exer (M) | +5,192 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
MASS Insider Holdings
16 insiders · @ $9.98
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Keith Crandell | Director | 5,764,419 | $57.56M | $6.00M | 8 | 2026-06-12 |
| 2 | AWM Investment Company, Inc. | 10%+ Owner | 4,736,773 | $47.30M | -$4.17M | 9 | 2026-10-01 |
| 3 | Kevin J. Knopp | President and CEO | 1,097,191 | $10.96M | -$10.90M | 41 | 2026-08-17 |
| 4 | Christopher D. Brown | Director | 775,559 | $7.74M | -$8.25M | 40 | 2026-11-06 |
| 5 | E Kevin Hrusovsky | Director | 495,065 | $4.94M | $1.00M | 8 | 2026-06-12 |
| 6 | Joseph H. Griffith IV | Chief Financial Officer | 116,497 | $1.16M | -$4.52M | 27 | 2026-10-08 |
| 7 | Mark Spoto | Director | 92,945 | $928.1K | $87.8K | 11 | 2026-06-12 |
| 8 | John Kenneweg | SVP, Sales & Product Marketing | 63,041 | $629.5K | -$3.29M | 16 | 2026-09-17 |
| 9 | Kevin J. McCallion | SVP, Products and Production | 44,925 | $448.6K | -$188.1K | 4 | 2026-04-14 |
| 10 | Anthony Hunt | Director | 44,168 | $441.0K | $0 | 9 | 2026-06-12 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
MASS Board & Officers
As of SEC filings through Nov 6, 2026Directors 9
- E Kevin Hrusovsky · since Dec 17, 2020
- Keith Crandell · since Dec 17, 2020
- Kevin J. Knopp · since Dec 17, 2020
- Mark Spoto · since Dec 17, 2020
- Fenel M Eloi · since Feb 22, 2021
- Anthony Hunt · since Mar 2, 2022
- Michele M. Leonhart · since Jun 25, 2024
- Christopher D. Brown · listed since Jun 2025
- Brandi C Vann · since Aug 1, 2025
Officers 7
- Kevin J. Knopp · President and CEO · since Dec 17, 2020
- Joseph H. Griffith IV · Chief Financial Officer · since Dec 17, 2020
- Michael S. Turner · Chief Legal & Admin Officer · listed since Feb 2024
- Mark S. Levine · Chief Legal and Admin. Officer · since Feb 26, 2026
- Kolawole A. Otitoju · Chief Bus. & Strategy Officer · since Apr 21, 2026
- Kevin J. McCallion · SVP, Products and Production · since Feb 26, 2026
- John Kenneweg · SVP, Sales & Product Marketing · listed since Mar 2026
10% owners 2
- AWM Investment Company, Inc. (entity) · since Mar 4, 2025
- Keith Crandell · since Dec 17, 2020
Changes in the last 10 years (42)
| Apr 21, 2026 | Kolawole A. Otitoju became Chief Bus. & Strategy Officer |
| Mar 6, 2026 | John Kenneweg listed as SVP, Sales & Product Marketing (previously Vice President, Government) in SEC filings |
| Feb 26, 2026 | Mark S. Levine became Chief Legal and Admin. Officer |
| Feb 26, 2026 | Kevin J. McCallion became SVP, Products and Production |
| Aug 1, 2025 | Brandi C Vann became a director |
| Jul 31, 2025 | The company announced the departure of Jeffrey P. George from the board in an SEC filing |
| Jun 18, 2025 | Christopher D. Brown first listed as a director in an SEC filing |
| Jun 12, 2025 | The company announced the departure of Marcia Eisenberg from the board in an SEC filing |
| Jun 12, 2025 | The company announced the departure of Christopher D. Brown as Chief Product Officer in an SEC filing |
| Mar 4, 2025 | AWM Investment Company, Inc. became a 10% owner |
| Jun 25, 2024 | Michele M. Leonhart became a director |
| Feb 2, 2024 | Michael S. Turner listed as Chief Legal & Admin Officer (previously VP, General Counsel) in SEC filings |
| Jun 9, 2023 | Christopher D. Brown listed as Chief Product Officer (previously Chief Technology Officer) in SEC filings |
| Jun 17, 2022 | Nicolas Barthelemy reported in an SEC filing no longer being a director |
| Jun 17, 2022 | Nicolas Barthelemy reported in an SEC filing no longer being VP, Corporate Development |
| Apr 29, 2022 | Michele Fournier became Chief People Officer |
| Apr 29, 2022 | Maura Fitzpatrick became VP, Product Management & Mktg |
| Mar 2, 2022 | Anthony Hunt became a director |
| Jun 25, 2021 | Trent A. Basarsky listed as VP, Corporate Development (previously Vice President, Commercial) in SEC filings |
| Jun 25, 2021 | Nicolas Barthelemy first listed as VP, Corporate Development in an SEC filing |
| Jun 7, 2021 | Marcia Eisenberg became a director |
| Feb 22, 2021 | Jeffrey P. George became a director |
| Feb 22, 2021 | Fenel M Eloi became a director |
| Dec 17, 2020 | Trent A. Basarsky became Vice President, Commercial |
| Dec 17, 2020 | Sharon Kedar became a director |
| Dec 17, 2020 | Robert Nelsen became a 10% owner |
| Dec 17, 2020 | Nicolas Barthelemy became a director |
| Dec 17, 2020 | Michael S. Turner became VP, General Counsel |
| Dec 17, 2020 | Mark Spoto became a director |
| Dec 17, 2020 | Kevin J. Knopp became a director |
| Dec 17, 2020 | Kevin J. Knopp became President and CEO |
| Dec 17, 2020 | Keith Crandell became a director |
| Dec 17, 2020 | Keith Crandell became a 10% owner |
| Dec 17, 2020 | Joseph H. Griffith IV became Chief Financial Officer |
| Dec 17, 2020 | John Michael Ramsey became a director |
| Dec 17, 2020 | John Kenneweg became Vice President, Government |
| Dec 17, 2020 | E Kevin Hrusovsky became a director |
| Dec 17, 2020 | Clinton Bybee became a 10% owner |
| Dec 17, 2020 | Christopher D. Brown became Chief Technology Officer |
| Dec 17, 2020 | ARCH Venture Partners VII, LLC became a 10% owner |
| Dec 17, 2020 | ARCH Venture Partners VII, L.P. became a 10% owner |
| Dec 17, 2020 | ARCH Venture Fund VII, L.P. became a 10% owner |
Not reported recently (10)
- Maura Fitzpatrick · Last reported as VP, Product Management & Mktg in an SEC filing dated Feb 3, 2023
- Michele Fournier · Last reported as Chief People Officer in an SEC filing dated May 9, 2022
- Trent A. Basarsky · Last reported as VP, Corporate Development in an SEC filing dated Apr 28, 2022
- Sharon Kedar · Last reported as a director in an SEC filing dated Dec 22, 2020
- Clinton Bybee · Last reported as a 10% owner in an SEC filing dated Dec 22, 2020
- ARCH Venture Partners VII, L.P. · Last reported as a 10% owner in an SEC filing dated Dec 22, 2020
- ARCH Venture Fund VII, L.P. · Last reported as a 10% owner in an SEC filing dated Dec 22, 2020
- ARCH Venture Partners VII, LLC · Last reported as a 10% owner in an SEC filing dated Dec 22, 2020
- Robert Nelsen · Last reported as a 10% owner in an SEC filing dated Dec 22, 2020
- John Michael Ramsey · Last reported as a director in an SEC filing dated Dec 21, 2020
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
MASS Proposed Insider Sales (Form 144)
Latest: 2026-10-06
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
6 filings
· $2.9M notice value
· 4 unique filers
· 100% under 10b5-1 plans
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Kevin Knopp (2, $1.6M) · CHRISTOPHER BROWN (1, $888K) · John Kenneweg (1, $269K) · Joseph Griffith (2, $189K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-10-06 | Joseph Griffith | Officer | 5,000 | $64.0K | 2026-10-06 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-09-15 | John Kenneweg | Officer | 27,656 | $269.1K | 2026-09-15 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-25 | Joseph Griffith | Officer | 11,459 | $125.1K | 2026-08-25 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-08-17 | Kevin Knopp | Officer | 20,000 | $205.0K | 2026-08-17 | Merrill Lynch | 10b5-1 | EDGAR |
| 2026-08-11 | Kevin Knopp | Officer | 140,000 | $1.35M | 2026-08-11 | Merrill Lynch | 10b5-1 | EDGAR |
| 2026-08-10 | CHRISTOPHER BROWN | Director | 100,000 | $888.0K | 2026-08-10 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-06-23 | Kevin Knopp | Officer | 80,000 | $724.0K | 2026-06-23 | Merrill Lynch | 10b5-1 | EDGAR |
| 2026-06-03 | CHRISTOPHER BROWN | Officer | 70,000 | $619.5K | 2026-06-03 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-05-28 | JOSEPH GRIFFITH | Officer | 6,940 | $56.6K | 2026-05-28 | Morgan Stanley Smith Barney LLC … | 10b5-1 | EDGAR |
| 2026-05-08 | JOHN WESLEY KENNEWEG | Officer, Director | 18,255 | $148.1K | 2026-05-08 | Morgan Stanley Smith Barney LLC … | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-10
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
| Filing Date | Accession | Link |
|---|
ETF Holders
32 ETFs hold MASS
25 shown · $48.67M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | AVUV Avantis U.S. Small Cap Value ETF | Avantis | 0.04% | $12.0M | $31.6B | 2026-11-06 |
| 2 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $11.4M | — | 2026-09-30 |
| 3 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.01% | $8.7M | $77.9B | 2026-11-06 |
| 4 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $4.6M | — | 2026-09-30 |
| 5 | IWN iShares Russell 2000 Value ETF | iShares (BlackRock) | 0.02% | $3.2M | $14.2B | 2026-11-06 |
| 6 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.01% | $2.3M | — | 2026-09-30 |
| 7 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.01% | $1.5M | — | 2026-08-31 |
| 8 | IWC iShares Micro-Cap ETF | iShares (BlackRock) | 0.09% | $1.0M | $1.2B | 2026-11-06 |
| 9 | FITE State Street® SPDR® S&P Kensho Future Security ETF | SPDR (State Street) | 0.66% | $934,570 | $141.8M | 2026-11-06 |
| 10 | AVSC Avantis U.S. Small Cap Equity ETF | Avantis | 0.02% | $675,375 | $3.2B | 2026-11-06 |
| 11 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.00% | $574,781 | — | 2026-11-06 |
| 12 | VTWV Vanguard Russell 2000 Value ETF | Vanguard | 0.03% | $361,118 | — | 2026-09-30 |
| 13 | AVUS Avantis U.S. Equity ETF | Avantis | 0.00% | $218,275 | $14.3B | 2026-11-06 |
| 14 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.00% | $200,513 | — | 2026-11-06 |
| 15 | RSSL Global X Russell 2000 ETF | Global X | 0.01% | $173,467 | — | 2026-11-09 |
| 16 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $165,385 | — | 2026-08-31 |
| 17 | DFAU Dimensional US Core Equity Market ETF | Dimensional | 0.00% | $131,314 | $12.9B | 2026-11-06 |
| 18 | SGRW Harbor Active Small Cap Growth ETF | Nport | 0.43% | $114,895 | — | 2026-07-31 |
| 19 | IWV iShares Russell 3000 ETF | iShares (BlackRock) | 0.00% | $87,701 | $20.4B | 2026-11-06 |
| 20 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $81,544 | — | 2026-11-06 |
| 21 | DFUS Dimensional US Equity Market ETF | Dimensional | 0.00% | $71,544 | $21.5B | 2026-11-06 |
| 22 | DFSU Dimensional US Sustainability Core 1 ETF | Dimensional | 0.00% | $48,301 | $2.4B | 2026-11-06 |
| 23 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $47,351 | — | 2026-11-06 |
| 24 | VTHR Vanguard Russell 3000 ETF | Vanguard | 0.00% | $26,568 | — | 2026-09-30 |
| 25 | ITWO ProShares Russell 2000 High Income ETF | ProShares | 0.01% | $20,292 | — | 2026-11-09 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-0.93
TTM Revenue
$60.84M
TTM Net Income
$-34.66M
TTM Op. Cash Flow
$1.49M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $16.07M | $-11.89M | $-0.32 | $3.17M |
| Q1 '26 | 2026-03-31 | $13.38M | $-11.96M | $-0.32 | $1.21M |
| Q4 '25 | 2025-12-31 | $17.38M | $4.17M | $0.11 | $1.32M |
| Q3 '25 | 2025-09-30 | $14.01M | $-14.98M | $-0.41 | $-4.20M |
| Q2 '25 | 2025-06-30 | $13.04M | $-13.31M | $-0.37 | $-5.78M |
| Q1 '25 | 2025-03-31 | $11.78M | $43.60M | $1.23 | $-15.02M |
| Q4 '24 | 2024-12-31 | $14.34M | $-19.45M | $-0.56 | $-2.24M |
| Q3 '24 | 2024-09-30 | $14.52M | $-29.30M | $-0.84 | $-5.61M |
| Q2 '24 | 2024-06-30 | $11.46M | $-12.55M | $-0.37 | $-13.04M |
| Q1 '24 | 2024-03-31 | $7.42M | $-10.92M | $-0.33 | $-9.36M |
| Q4 '23 | 2023-12-31 | $14.35M | $-7.43M | $-0.23 | $-1.93M |
| Q3 '23 | 2023-09-30 | $14.30M | $-7.09M | $-0.22 | $-4.60M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-11
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
2.89
P/S
6.03
EV/EBITDA
—
EV/Sales
4.99
ROE
-27.3%
ROA
-17.5%
Div Yield
0.00%
FCF Yield
0.41%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$366.64M
as of 2026-11-10
MASS vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| LLY Eli Lilly & Co. | $1.26T | 46.2 | +45.5% | +31.7% | 36 |
| NTRA Natera, Inc. Common Stock | $46.5B | — | +36.6% | +40.7% | 39 |
| GH Guardant Health, Inc. Common Stock | $21.5B | — | +42.7% | +57.9% | 23 |
| TEM Tempus AI, Inc. Class A Common Stock | $15.4B | — | +36.6% | +34.0% | 69 |
| TWST Twist Bioscience Corporation Common Stoc | $9.0B | — | +17.8% | +340.4% | 84 |
| TXG 10x Genomics, Inc. Class A Common Stock | $8.6B | — | +2.3% | +305.2% | 37 |
| CRSP CRISPR Therapeutics AG | $4.9B | — | −34.3% | −15.4% | 52 |
| ABSI Absci Corporation Common Stock | $1.9B | — | −62.3% | +184.2% | 31 |
| MASS 908 Devices Inc. Common Stock | $476M | — | +13.4% | +109.6% | 29 |
| Peer median | $12.2B | 46.2 | +27.2% | +49.3% | 38 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
2.71M
SI % of Float
8.70%
Days to Cover
7.12
Short Vol Ratio
72.4%
Free Float
31.14M
Float %
75.3%
Short interest 2026-10-15 • Short volume 2026-11-10 • Float 2026-08-24